annual EBIT:
-$333.08M+$132.53M(+28.46%)Summary
- As of today (May 29, 2025), ASND annual earnings before interest & taxes is -$333.08 million, with the most recent change of +$132.53 million (+28.46%) on December 31, 2024.
- During the last 3 years, ASND annual EBIT has risen by +$116.57 million (+25.92%).
- ASND annual EBIT is now -5421.34% below its all-time high of $6.26 million, reached on December 31, 2013.
Performance
ASND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$51.33M-$6.16M(-13.65%)Summary
- As of today (May 29, 2025), ASND quarterly earnings before interest & taxes is -$51.33 million, with the most recent change of -$6.16 million (-13.65%) on March 31, 2025.
- Over the past year, ASND quarterly EBIT has increased by +$4.47 million (+8.01%).
- ASND quarterly EBIT is now -2450.67% below its all-time high of $2.18 million, reached on December 31, 2013.
Performance
ASND quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$272.99M+$4.47M(+1.61%)Summary
- As of today (May 29, 2025), ASND TTM earnings before interest & taxes is -$272.99 million, with the most recent change of +$4.47 million (+1.61%) on March 31, 2025.
- Over the past year, ASND TTM EBIT has increased by +$132.99 million (+32.76%).
- ASND TTM EBIT is now -12602.29% below its all-time high of $2.18 million, reached on December 31, 2013.
Performance
ASND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ASND EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.5% | +8.0% | +32.8% |
| 3 y3 years | +25.9% | +61.8% | +44.9% |
| 5 y5 years | -37.1% | +26.1% | -12.7% |
ASND EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.3% | -13.7% | +74.5% | at high | +53.0% |
| 5 y | 5-year | -37.1% | +42.3% | -13.7% | +75.7% | -12.7% | +53.0% |
| alltime | all time | -5421.3% | +42.3% | -2450.7% | +75.7% | <-9999.0% | +53.0% |
ASND EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$51.33M(+13.6%) | -$272.99M(-1.6%) |
| Dec 2024 | -$333.08M(-28.5%) | -$45.16M(-43.6%) | -$277.45M(-10.7%) |
| Sep 2024 | - | -$80.10M(-16.9%) | -$310.54M(-18.2%) |
| Jun 2024 | - | -$96.40M(+72.8%) | -$379.67M(-6.5%) |
| Mar 2024 | - | -$55.79M(-28.7%) | -$405.98M(-11.2%) |
| Dec 2023 | -$465.61M(-19.3%) | -$78.25M(-47.6%) | -$457.35M(-21.2%) |
| Sep 2023 | - | -$149.23M(+21.6%) | -$580.30M(+3.6%) |
| Jun 2023 | - | -$122.70M(+14.5%) | -$559.89M(+9.0%) |
| Mar 2023 | - | -$107.16M(-46.7%) | -$513.80M(-5.1%) |
| Dec 2022 | -$577.01M(+28.3%) | -$201.20M(+56.2%) | -$541.13M(+17.7%) |
| Sep 2022 | - | -$128.82M(+68.1%) | -$459.84M(+8.3%) |
| Jun 2022 | - | -$76.62M(-43.0%) | -$424.72M(-14.3%) |
| Mar 2022 | - | -$134.49M(+12.2%) | -$495.50M(+13.7%) |
| Dec 2021 | -$449.65M(-5.6%) | -$119.91M(+28.0%) | -$435.85M(-17.4%) |
| Sep 2021 | - | -$93.69M(-36.4%) | -$527.52M(-0.4%) |
| Jun 2021 | - | -$147.39M(+96.9%) | -$529.47M(+11.4%) |
| Mar 2021 | - | -$74.85M(-64.6%) | -$475.41M(+1.1%) |
| Dec 2020 | -$476.52M(+96.1%) | -$211.58M(+121.2%) | -$470.02M(+35.4%) |
| Sep 2020 | - | -$95.65M(+2.5%) | -$347.02M(+24.4%) |
| Jun 2020 | - | -$93.33M(+34.4%) | -$278.96M(+15.1%) |
| Mar 2020 | - | -$69.46M(-21.6%) | -$242.33M(+3.7%) |
| Dec 2019 | -$242.96M | -$88.58M(+221.1%) | -$233.65M(+28.7%) |
| Sep 2019 | - | -$27.58M(-51.4%) | -$181.57M(-6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$56.70M(-6.7%) | -$193.56M(+17.9%) |
| Mar 2019 | - | -$60.79M(+66.5%) | -$164.16M(+12.7%) |
| Dec 2018 | -$153.94M(+9.4%) | -$36.50M(-7.7%) | -$145.72M(-10.2%) |
| Sep 2018 | - | -$39.56M(+44.9%) | -$162.24M(+1.7%) |
| Jun 2018 | - | -$27.31M(-35.5%) | -$159.49M(+0.2%) |
| Mar 2018 | - | -$42.35M(-20.1%) | -$159.15M(+12.3%) |
| Dec 2017 | -$140.74M(+85.0%) | -$53.03M(+44.1%) | -$141.76M(+29.1%) |
| Sep 2017 | - | -$36.81M(+36.5%) | -$109.80M(+18.0%) |
| Jun 2017 | - | -$26.97M(+8.0%) | -$93.05M(+14.6%) |
| Mar 2017 | - | -$24.96M(+18.5%) | -$81.17M(+6.9%) |
| Dec 2016 | -$76.06M(+104.2%) | -$21.07M(+5.1%) | -$75.93M(+6.5%) |
| Sep 2016 | - | -$20.05M(+32.8%) | -$71.29M(+20.4%) |
| Jun 2016 | - | -$15.09M(-23.4%) | -$59.23M(+1.6%) |
| Mar 2016 | - | -$19.72M(+20.0%) | -$58.32M(+57.9%) |
| Dec 2015 | -$37.25M(+171.3%) | -$16.43M(+105.6%) | -$36.94M(+32.6%) |
| Sep 2015 | - | -$7.99M(-43.7%) | -$27.87M(+24.5%) |
| Jun 2015 | - | -$14.19M(-951.2%) | -$22.38M(+102.6%) |
| Mar 2015 | - | $1.67M(-122.7%) | -$11.05M(-17.2%) |
| Dec 2014 | -$13.73M(-319.3%) | -$7.35M(+193.0%) | -$13.35M(+250.3%) |
| Sep 2014 | - | -$2.51M(-12.0%) | -$3.81M(+193.0%) |
| Jun 2014 | - | -$2.85M(+350.5%) | -$1.30M(-183.9%) |
| Mar 2014 | - | -$632.90K(-129.0%) | $1.55M(-29.0%) |
| Dec 2013 | $6.26M(+273.1%) | $2.18M | $2.18M |
| Dec 2012 | $1.68M | - | - |
FAQ
- What is Ascendis Pharma A/S annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual EBIT year-on-year change?
- What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
- What is Ascendis Pharma A/S TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM EBIT year-on-year change?
What is Ascendis Pharma A/S annual earnings before interest & taxes?
The current annual EBIT of ASND is -$333.08M
What is the all time high annual EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual earnings before interest & taxes is $6.26M
What is Ascendis Pharma A/S annual EBIT year-on-year change?
Over the past year, ASND annual earnings before interest & taxes has changed by +$132.53M (+28.46%)
What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of ASND is -$51.33M
What is the all time high quarterly EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly earnings before interest & taxes is $2.18M
What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
Over the past year, ASND quarterly earnings before interest & taxes has changed by +$4.47M (+8.01%)
What is Ascendis Pharma A/S TTM earnings before interest & taxes?
The current TTM EBIT of ASND is -$272.99M
What is the all time high TTM EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM earnings before interest & taxes is $2.18M
What is Ascendis Pharma A/S TTM EBIT year-on-year change?
Over the past year, ASND TTM earnings before interest & taxes has changed by +$132.99M (+32.76%)